eotaxin (CCL11),

epidermal growth factor (EGF),

fibroblast growth factor 2 (FGF-2, also known as FGF-basic),

fractalkine (CX3CL1),

granulocyte colony-stimulating factor (G-CSF),

granulocyte-macrophage colony-stimulating factor (GM-CSF),

growth-regulated oncogene α (GROα),

interferonγ(IFNγ),

interferonα2 (IFNα2),

interferon γ–induced protein 10(IP-10, also known as CXCL10),

interleukin 1 receptor antagonist (IL-1Ra),

interleukin 1α (IL-1α),

interleukin 1β(IL-1β),

interleukin 10 (IL-10),

interleukin 12 (IL-12 (p40)),

interleukin 12 (IL-12 (p70)),

interleukin 13 (IL-13),

interleukin 15 (IL-15),

interleukin 17A (IL-17A, also known as CTLA8),

interleukin 2 (IL-2),

interleukin 3 (IL-3),

interleukin 4 (IL-4),

interleukin 5 (IL-5),

interleukin 6 (IL-6),

interleukin 7 (IL-7),

interleukin 8 (IL-8, also known as CXCL8),

interleukin 9 (IL-9),

ligand of Fms-like tyrosine kinase 3 (Flt3 ligand),

macrophage inflammatory protein1α (MIP-1α, also known as CCL3),

macrophage inflammatory protein1β (MIP-1β, also known as CCL4),

macrophage-derived chemokine (MDC, also known as CCL22),

monocyte chemoattractant protein 1(MCP-1, also known as CCL2),

monocyte chemoattractant protein 3 (MCP-3, also known as CCL7),

platelet-derived growth factor AA (PDGF-AA),

platelet-derived growth factor AB (PDGF-AB/BB),

regulated upon activation, normal T cell expressed and presumably secretedchemokine (RANTES, also known as CCL5),

soluble ligand of CD40 (sCD40L),

transforming growth factor α (TGFα),

tumor necrosis factor α (TNFα),

tumor necrosis factor β (TNFβ, also known as lymphotoxin-α (LTA)),

vascular endothelial growth factor A (VEGF-A).